Walleye Capital
AFIB

Walleye Capital’s Acutus Medical Inc AFIB Stock Holding History

Walleye Capital’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-65,004
Closed -$222K – 2685
2021
Q4 		$222K Buy
+65,004
New +$366K 0.01% 1412
2021
Q2 		– Sell
-19,744
Closed -$264K – 1556
2021
Q1 		$264K Buy
+19,744
New +$445K 0.02% 823

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Walleye Capital's AFIB Position: Q1 2022 in Review

Walleye Capital sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 65,004 shares — an estimated $222K sold.

Walleye Capital first reported a position in AFIB in Q1 2021 and held it in 2 quarters. The position peaked at $264K in Q1 2021. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

  • Walleye Capital reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Walleye Capital sold 65,004 Acutus Medical Inc shares in Q1 2022, an estimated $222K.
  • Walleye Capital first reported a position in Acutus Medical Inc in Q1 2021 and held it in 2 quarters.
  • Walleye Capital's Acutus Medical Inc position peaked at $264K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.